Retail cannabis distribution in Colorado is associated with a reduction in opioid-related mortality, according to data published online ahead of print in The American Journal of Public Health.
A team of investigators from the University of North Texas School of Public Health, the University of Florida, and Emory University compared changed in the prevalence of monthly opioid-related deaths before and after Colorado retailers began selling cannabis to adults.
They reported: “Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado.”
Authors concluded, “Legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths.”
Their data is consistent with prior studies finding that cannabis access is associated with reductions in prescription drug spending, opioid-related hospitalizations, and opioid-related fatalities.
An abstract of the study, “Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015,” appears online here.
